KLK3 and prostate cancer: The robust and rapid uptake of prostate-specific antigen (PSA) testing for prostate cancer despite the lack of clear evidence of efficacy can, in part, be attributed to the fact that it is a blood test and can be administered as a routine part of a standard physical in which blood is taken for cholesterol, glucose, and other substances.